Another non-surprise, since we knew early in January [TTA 7 Jan] that Watson Health was on the exit side of the IBM ledger. Francisco Partners, a private equity company, is picking up the healthcare and data analytics assets of Watson Health. These include, according to the joint release, “extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings.”
The company will be standalone and the current executive team will continue to serve their clients in the life sciences, provider, imaging, payer and employer, and government health and human services sectors.
Francisco Partners has $30 billion in assets under management and over time has invested in over 400 companies. Their current healthcare companies include GoodRx, ZocDoc, and TrellisRx.
Financial terms were not disclosed, but IBM was seeking bids in the $1 billion range. It’s also known that IBM spent well in excess of $4 billion to build the company, was earning about $1 billion in revenue sans profit, so it can be charitably called a fire sale to get it off the IBM books. In any case, barring regulatory glitches, the sale is expected to close in second quarter 2022. Also HealthcareITNews, Becker’s HealthIT, HISTalk
Most Recent Comments